Search results
Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past...
Simply Wall St. via Yahoo Finance· 4 days agoKey Insights Significantly high institutional ownership implies Moderna's stock price is sensitive...
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 3 days agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
Moderna director Noubar Afeyan sells over $1.8m in company stock By Investing.com
Investing.com· 3 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant amount of...
Company News For May 13, 2024
Zacks via Yahoo Finance· 8 hours agoNovavax, Inc. (NVAX) shares surged 98.7% after announcing a $1.2 billion deal with Sanofi (SNY) to commercialize a combined COVID-19 and flu vaccine. ...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 5 days agoModerna stock broke out for the first time in over a year on May 2 after the biotech company notched...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters via AOL· 3 days agoModerna's shares fell 3% to $119.02 in early trading. The Food and Drug Administration's move...
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
CNBC· 3 hours agoA vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022....
Wealthspire Advisors LLC Has $301,000 Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 2 days agoWealthspire Advisors LLC trimmed its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 7.9% in the fourth quarter, according to its most recent disclosure with the Securities ...
Moderna (NASDAQ:MRNA) PT Raised to $106.00
ETF DAILY NEWS· 7 days agoModerna (NASDAQ:MRNA – Free Report) had its price target increased by Canaccord Genuity Group from $91.00 to $106.00 in a report published on Friday, Benzinga reports. Canaccord ...
Moderna shares target raised to $85 by Deutsche Bank By Investing.com
Investing.com· 4 days agoOn Thursday, Deutsche Bank (ETR:DBKGn) revised its price target for Moderna (NASDAQ:MRNA) shares,...
